A61K9/122

ANTIMICROBIAL COMPOSITION

An anti-microbial composition including: a solvent; a cationic active ingredient; a source of zinc ions, wherein the zinc ions have a concentration from 6.2×10.sup.−4 to 8.7×10.sup.−3 mol/L; and an amine oxide surfactant. A method of selectively killing Gram-positive bacteria, the method including: exposing bacteria to a formulation including: 0.05 to 0.3 wt. % of benzethonium chloride and/or benzalkonium chloride; a source of zinc ions, wherein the zinc ions have a concentration from 6.8×10.sup.−3 to 2×10.sup.−2 mol/L; and an amine oxide surfactant.

HIGH QUALITY NON-AEROSOL HAND SANITIZING FOAM
20170231437 · 2017-08-17 ·

Exemplary embodiments of high non-aerosol foam sanitizers are disclosed herein. An exemplary embodiment of high non-aerosol foam sanitizer includes a liquid mixture that includes an alcohol, water and a surfactant mixed with and entrapping air to form a plurality of foam bubbles. Wherein more than about 50 percent of the foam bubbles have a size of between about 50 μm and about 250 μm.

Topical oily foam compositions

Topical alcohol-free thermo labile oily foam composition comprising (i) at least one active pharmaceutical ingredient or ectoparasitic active ingredient; (ii) at least about 20% w/w of at least one lipophilic component; (iii) at least about 10% w/w of at least one non-ionic surfactant; (iv) at least about 0.5% w/w of at least one fatty alcohol or fatty acid or ester thereof with melting point above 30° C., and; (v) at least about 7% w/w of propellant selected from propane, butane, isobutane and combinations thereof;
said composition optionally comprising at least about 5% to about 70% w/w of a hydrophilic component, optionally comprising up to about 5% w/w hydrogenated oil and optionally comprising a penetration enhancer.

System and method of testing for leaks after anastomosis
11452481 · 2022-09-27 · ·

Devices, kits, and methods for testing the integrity of a cavity within an anatomical organ. For example, the devices, kits, and methods described herein are useful for detecting leaks in an anastomosis or for testing the integrity or repair of a defect in anatomy.

No-rinse chemical foam containing brimonidine, and use thereof in the treatment of rosacea

A self-foaming composition is described that includes brimonidine, for a no-rinse topical application. The composition can include: at least one intermediate composition B including a gas-generating agent; at least one intermediate composition A including an agent for activating the gas-generating agent; and brimonidine or one of the pharmaceutically acceptable salts thereof being present in at least one of the intermediate compositions A and B. Also described, is a kit or a single container including a plurality of compartments including such a composition.

A Dextran Coated Silica Aerogel Used as a Drug Carrier System and a Dextran Coated Silica Aerogel Production Method

The present invention relates to a dextran (D) coated silica aerogel used as a drug carrier system in colon cancer treatment and a dextran (D) coated silica aerogel production method in which silica aerogels were synthesized with the Sol-Gel method are modified with amine groups and are coated with dextran (D) or dextran aldehyde (DA) to obtain said dextran (D) coated silica aerogel (S).

Method and compositions for treating psoriasis
09717741 · 2017-08-01 · ·

Method and composition for treating psoriasis and other skin disorders.

Foam-formed collagen strand

Foam-formed collagen strands and methods for forming strands involve depositing a dispersed solution of an isolated cleaned, de-fatted, enzymatically-treated (or non-enzyme treated) human-derived collagen product having a preserved amount of its natural constituents into grooves of a grooved plate, and processing the dispersed collagen product to provide a foam-formed collagen strand. Foam-formed collagen strands may be processed into threads having a matrix of reticulated pores to conduct biological materials in and through the strand, the collagen of the collagen strand comprising isolated, enzymatically-treated human derived collagen having a preserved amount of its natural collagen constituents.

Synthetic Multiphase Systems

A synthetic multiphase product comprising BsIA is presented. Methods of producing a synthetic multiphase product comprising BsIA, and applications of BsIA in synthetic multiphase products are also presented.

SHELF-STABLE FOAM-LIKE CONFECTIONARIES COMPRISING ERYTHRITOL AND ACTIVE INGREDIENTS
20170258913 · 2017-09-14 ·

In one embodiment, a confectionary comprises 50 to 75 wt. % erythritol, 0 to 75 wt. % of at least one additional sweetener, at least one stabilizer, water, and a first active ingredient. The water may comprise 0.5 to 3 wt. % of the confectionary. The water may have a water activity of from 0.3 to 0.5. The confectionary may be aerated such that the density of the confectionary is 0.05 to 0.3 grams per cubic centimeter.